Top

Virology Journal

Published in:

Open Access 01-12-2023 | Epstein-Barr Virus | Research

Epstein Barr virus infection in tree shrews alters the composition of gut microbiota and metabolome profile

Authors: Wei Xia, Lei Liu, Nan Shi, Chaoyin Zhang, Anzhou Tang, Guangyao He

Published in: Virology Journal | Issue 1/2023

Abstract

Background

Epstein-Barr virus (EBV) infection is a major global threat; its manifestations range from the absence of symptoms to multiorgan malignancies and various gastrointestinal diseases. Analyzing the composition and metabolomic profile of gut microbiota during acute EBV infection might be instrumental in understanding and controlling EBV.

Methods

Six tree shrews were inoculated with EBV by intravenous injection. Blood was collected at regular intervals thereafter from the femoral vein to detect EBV and inflammatory biomarker. At the same time, tree shrew faeces were collected for 16 S rRNA gene sequencing and Non-targeted metabolomics analysis.

Results

16 S rRNA gene characterization along with β diversity analysis exhibited remarkable alterations in gut microflora structure with a peak at 7 days post-infection(dpi). Some alterations in the relative richness of bacterial taxon were linked to infectious indicators. Of note, Butyricicoccus relative richness was positively linked to EBV presence in the blood and plasma, the opposite correlation was seen with Variovorax and Paramuribaculum. Non-targeted metabolomics indicated the fecal metabolome profile altered during EBV infection, particularly 7 dpi. The relative abundance of geranic acid and undecylenic acid in stool samples was positively linked to systemic inflammatory biomarkers, and an inverse relationship was reported with the estrone glucuronide, linoleic acid, protoporphyrin IX and tyramine.

Conclusion

Collectively, EBV infection in this model correlated with changes in the composition and metabolome profile of the gut microbiota.

Available only for authorised users

Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004;70:1279–87.PubMed

Jenson HB. Epstein-Barr virus. Pediatr Rev. 2011;32:375–83. https://doi.org/10.1542/pir.32-9-375. quiz 384.CrossRefPubMed

Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017. https://doi.org/10.1098/rstb.2016.0271.CrossRefPubMedPubMedCentral

Crawford DH. Biology and disease associations of Epstein-Barr virus. Philosophical transactions of the Royal Society of London. Ser B Biol Sci. 2001;356:461–73. https://doi.org/10.1098/rstb.2000.0783.CrossRef

Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108–21. https://doi.org/10.1038/sj.onc.1206556.CrossRefPubMed

Bertalot G, Villanacci V, Gramegna M, Orvieto E, Negrini R, Saleri A, et al. Evidence of Epstein-Barr virus infection in ulcerative colitis. Dig Liver Dis. 2001;33:551–8. https://doi.org/10.1016/s1590-8658(01)80106-7.CrossRefPubMed

Liu R, Wang M, Zhang L, Zhou W, Huang Y, Guo H, et al. The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis. Mod Pathol. 2019;32:387–95. https://doi.org/10.1038/s41379-018-0144-1.CrossRefPubMed

Ryan JL, Shen Y-J, Morgan DR, Thorne LB, Kenney SC, Dominguez RL, Gulley ML. Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci. 2012;57:1887–98. https://doi.org/10.1007/s10620-012-2116-5.CrossRefPubMedPubMedCentral

Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990–2010. Infect Agent Cancer. 2014;9:38. https://doi.org/10.1186/1750-9378-9-38.CrossRefPubMedPubMedCentral

10.

Deriu E, Boxx GM, He X, Pan C, Benavidez SD, Cen L, et al. Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I Interferons. PLoS Pathog. 2016;12:e1005572. https://doi.org/10.1371/journal.ppat.1005572.CrossRefPubMedPubMedCentral

11.

Bartley JM, Zhou X, Kuchel GA, Weinstock GM, Haynes L. Impact of Age, caloric restriction, and Influenza infection on mouse gut microbiome: an exploratory study of the role of age-related Microbiome changes on influenza responses. Front Immunol. 2017;8:1164. https://doi.org/10.3389/fimmu.2017.01164.CrossRefPubMedPubMedCentral

12.

Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, et al. Microbiota-Driven Tonic Interferon signals in lung stromal cells protect from Influenza Virus infection. Cell Rep. 2019;28:245–256e4. https://doi.org/10.1016/j.celrep.2019.05.105.CrossRefPubMed

13.

Corrêa R, de Oliveira Santos I, Braz-de-Melo HA, de Sant’Ana LP, Almeida dasN, Pasquarelli-do-Nascimento R. Gut microbiota modulation induced by Zika virus infection in immunocompetent mice. Sci Rep. 2021;11:1421. https://doi.org/10.1038/s41598-020-80893-y.CrossRefPubMedPubMedCentral

14.

D’Angelo C, Reale M, Costantini E. Microbiota and Probiotics in Health and HIV infection. Nutrients. 2017. https://doi.org/10.3390/nu9060615.CrossRefPubMedPubMedCentral

15.

Fujiwara S, Nakamura H. Animal models for Gammaherpesvirus Infections: recent development in the analysis of Virus-Induced Pathogenesis. Pathogens. 2020;9:116. https://doi.org/10.3390/pathogens9020116.CrossRefPubMedPubMedCentral

16.

Dittmer DP, Damania B, Sin SH. Animal models of tumorigenic herpesviruses—an update. Curr Opin Virol. 2015;14:145–50. https://doi.org/10.1016/j.coviro.2015.09.006.CrossRefPubMedPubMedCentral

17.

Fan Y, Huang ZY, Cao CC, Chen CS, Chen YX, Fan DD, et al. Genome of the chinese tree shrew. Nat Commun. 2013;4:1426. https://doi.org/10.1038/ncomms2416.CrossRefPubMed

18.

Xiang Z, Zhu H, Yang B, Fan H, Guo J, Liu J, et al. A glance at the gut microbiota of five experimental animal species through fecal samples. Sci Rep. 2020;10:16628. https://doi.org/10.1038/s41598-020-73985-2.CrossRefPubMedPubMedCentral

19.

Gu W, Li W, Wang W, Kuang D, Zhang W, Lu C, et al. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans. BMC Microbiol. 2020;20:260. https://doi.org/10.1186/s12866-020-01943-z.CrossRefPubMedPubMedCentral

20.

Li R, Zanin M, Xia X, Yang Z. The tree shrew as a model for infectious diseases research. J Thorac Dis. 2018;10:2272–S2279. https://doi.org/10.21037/jtd.2017.12.121.CrossRef

21.

Kayesh MEH, Sanada T, Kohara M, Tsukiyama-Kohara K. Tree Shrew as an emerging small animal model for human viral infection: a recent overview. Viruses. 2021. https://doi.org/10.3390/v13081641.CrossRefPubMedPubMedCentral

22.

Feng Y, Feng Y-M, Lu C, Han Y, Liu L, Sun X, et al. Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo. J Gen Virol. 2017;98:2069–78. https://doi.org/10.1099/jgv.0.000869.CrossRefPubMedPubMedCentral

23.

Xia W, Chen H, Feng Y, Shi N, Huang Z, Feng Q, et al. Tree Shrew is a suitable animal model for the study of Epstein Barr Virus. Front Immunol. 2021;12:789604. https://doi.org/10.3389/fimmu.2021.789604.CrossRefPubMed

24.

Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D et al. Proteins of purified Epstein-Barr virus. Proceedings of the National Academy of Sciences. 2004;101:16286–91. https://doi.org/10.1073/pnas.0407320101.

25.

Tan LP, Tan GW, Sivanesan VM, Goh SL, Ng XJ, Lim CS, et al. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma. Int J Cancer. 2020;146:2336–47. https://doi.org/10.1002/ijc.32656.CrossRefPubMed

26.

Whitaker AM. The chromosomes of the Namalwa cell line. J Biol Stand. 1985;13:173–IN3. https://doi.org/10.1016/s0092-1157(85)80024-x.CrossRefPubMed

27.

BENTLEYLAWRENCE J. Sensitive, high-resolution chromatin and chromosome mapping in situ: Presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell. 1988;52:51–61. https://doi.org/10.1016/0092-8674(88)90530-2.

28.

Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852–7. https://doi.org/10.1038/s41587-019-0209-9.CrossRefPubMedPubMedCentral

29.

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–6. https://doi.org/10.1093/nar/gks1219.CrossRefPubMed

30.

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.CrossRefPubMedPubMedCentral

31.

Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779–87. https://doi.org/10.1021/ac051437y.CrossRefPubMed

32.

Dreyfus DH. Herpesviruses and the microbiome. J Allergy Clin Immunol. 2013;132:1278–86. https://doi.org/10.1016/j.jaci.2013.02.039.CrossRefPubMed

33.

Tang L-Q, Li C-F, Chen Q-Y, Zhang L, Lai X-P, He Y, et al. High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study. Int J Radiat Oncol Biol Phys. 2015;91:325–36. https://doi.org/10.1016/j.ijrobp.2014.10.005.CrossRefPubMed

34.

Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. Microbial Co-occurrence Relationships in the human microbiome. PLoS Comput Biol. 2012. https://doi.org/10.1371/journal.pcbi.1002606.CrossRefPubMedPubMedCentral

35.

Zhang J, Liu J, Yuan Y, Huang F, Ma R, Luo B, et al. Two waves of pro-inflammatory factors are released during the influenza a virus (IAV)-driven pulmonary immunopathogenesis. PLoS Pathog. 2020. https://doi.org/10.1371/journal.ppat.1008334.CrossRefPubMedPubMedCentral

36.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;1–3. https://doi.org/10.1007/s00134-020-05991-x.

37.

Sun Z, Huang C, Shi Y, Wang R, Fan J, Yu Y, et al. Distinct bile acid profiles in patients with chronic Hepatitis B virus infection reveal metabolic interplay between host, Virus and Gut Microbiome. Front Med (Lausanne). 2021. https://doi.org/10.3389/fmed.2021.708495.CrossRefPubMedPubMedCentral

38.

Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AYL, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706. https://doi.org/10.1136/gutjnl-2020-323020.CrossRefPubMed

39.

Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS. Respiratory viral infection alters the gut microbiota by inducing Inappetence. MBio. 2020. https://doi.org/10.1128/mBio.03236-19.CrossRefPubMedPubMedCentral

40.

Stefan KL, Kim MV, Iwasaki A, Kasper DL. Commensal microbiota modulation of Natural Resistance to Virus infection. Cell. 2020;183:1312–1324e10. https://doi.org/10.1016/j.cell.2020.10.047.CrossRefPubMedPubMedCentral

41.

Zhu Q, Xia P, Zhou X, Li X, Guo W, Zhu B, et al. Hepatitis B Virus infection alters gut microbiota composition in mice. Front Cell Infect Microbiol. 2019;9:377. https://doi.org/10.3389/fcimb.2019.00377.CrossRefPubMedPubMedCentral

42.

Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol. 2018;9:182. https://doi.org/10.3389/fimmu.2018.00182.CrossRefPubMedPubMedCentral

43.

Qin N, Zheng B, Yao J, Guo L, Zuo J, Wu L, et al. Influence of H7N9 virus infection and associated treatment on human gut microbiota. Sci Rep. 2015;5:14771. https://doi.org/10.1038/srep14771.CrossRefPubMedPubMedCentral

44.

Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. Alterations of the gut microbiota in patients with Coronavirus Disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71:2669–78. https://doi.org/10.1093/cid/ciaa709.CrossRefPubMed

45.

Huang H, Ren Z, Gao X, Hu X, Zhou Y, Jiang J, et al. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med. 2020;12:102. https://doi.org/10.1186/s13073-020-00796-5.CrossRefPubMedPubMedCentral

46.

Preveden T, Scarpellini E, Milić N, Luzza F, Abenavoli L. Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol. 2017;11:813–9. https://doi.org/10.1080/17474124.2017.1343663.CrossRefPubMed

47.

Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until Discharge. Gastroenterology. 2020;159:1302–1310e5. https://doi.org/10.1053/j.gastro.2020.06.048.CrossRefPubMed

48.

Li X, Wu S, Du Y, Yang L, Li Y, Hong B. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model. Int J Antimicrob Agents. 2020;56:106000. https://doi.org/10.1016/j.ijantimicag.2020.106000.CrossRefPubMed

49.

Winkler ES, Thackray LB. A long-distance relationship: the commensal gut microbiota and systemic viruses. Curr Opin Virol. 2019;37:44–51. https://doi.org/10.1016/j.coviro.2019.05.009.CrossRefPubMedPubMedCentral

50.

Lieberman PM. Virology. Epstein-Barr virus turns 50. Science. 2014;343:1323–5. (New York, N.Y.). https://doi.org/10.1126/science.1252786.

51.

Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789–802. https://doi.org/10.1038/nrc.2016.92.CrossRefPubMed

52.

Vetsika E-K, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med. 2004;6:1–16. https://doi.org/10.1017/S1462399404008440.CrossRefPubMed

Title: Epstein Barr virus infection in tree shrews alters the composition of gut microbiota and metabolome profile
Authors: Wei Xia
Lei Liu
Nan Shi
Chaoyin Zhang
Anzhou Tang
Guangyao He
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Epstein-Barr Virus
Respiratory Microbiota
Published in: Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/s12985-023-02147-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?

Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020

Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China

Enterovirus B types cause severe infection in infants aged 0–3 months

Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage